Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/2002
10/03/2002WO2002076438A2 Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
10/03/2002WO2002076422A1 Use of a mixture comprising mn(ii) and/or zn(ii) with a hydrogenocarbonate and at least an orthodiphenol, as agent reducing adhesion of micro-organisms
10/03/2002WO2002076415A1 Anti-dandruff agent
10/03/2002WO2002076411A2 Dermatological agent for the treatment of skin trauma, especially in burn conditions
10/03/2002WO2002076410A2 Cosmetic and dermatological preparations comprising a content of a hop extract or hop-malt extract
10/03/2002WO2002076409A2 Cosmetic and dermatological preparations comprising an isoflavone content
10/03/2002WO2002076408A2 Use of creatine, creatinine and/or derivatives thereof
10/03/2002WO2002076405A2 Compositions and methods of treatment of ulcerating diseases, burns, and related conditions
10/03/2002WO2002076404A2 Fatty alcohol drug conjugates
10/03/2002WO2002076402A2 Fatty amine drug conjugates
10/03/2002WO2002076401A2 Method of attenuating reactions to skin irritants
10/03/2002WO2002076400A2 Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease
10/03/2002WO2002076196A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
10/03/2002WO2002062784A8 Piperidinee derivatives as neurokinin 1 antagonists
10/03/2002WO2002051436A3 Stable enzymatic wound debrider
10/03/2002WO2002022677A3 Variants of allergenic proteins of the group 2 of dermatophagoides
10/03/2002WO2002018407A3 Antisense oligonucleotides against vanilloid receptor 1
10/03/2002WO2002014349A3 Non-covalent inhibitors of urokinase and blood vessel formation
10/03/2002WO2001071004A3 Proteases
10/03/2002WO2001021812A9 Phosphatases which activate map kinase pathways
10/03/2002WO2001019800A9 Mediators of hedgehog signaling pathways, compositions and uses related thereto
10/03/2002WO2001017508A9 Cationic liposome delivery of taxanes to angiogenic blood vessels
10/03/2002US20020143069 For therapy of polymorphoneutrophil (PMN) inflammation
10/03/2002US20020143066 Perylenequinones for use as photosensitizers and sonosensitizers
10/03/2002US20020143057 Using diacerein or a pharmaceutically acceptable derivative or rhein for the manufacture of a pharmaceutical formulation for the treatment of psoriasis and diseases associated therewith
10/03/2002US20020143055 Administering an effective amount of propionoyloxymethyl propionate, butyroyloxymethyl butyrate, or mixtures for therapy of illness
10/03/2002US20020143039 Methods and compositions for the treatment of alopecia and other disorders of the pilosebaceous apparatus
10/03/2002US20020143032 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
10/03/2002US20020143026 Induce mitotic arrest thereby making them useful as anti-cancer agents; also for therapy of diseases which can be treated by inducing mitotic arrest
10/03/2002US20020143020 Novel piperazine derivatives
10/03/2002US20020143009 Novel bicyclic oxazolidinones as antibacterial agents
10/03/2002US20020142983 MUC-1 antagonists and methods of treating immune disorders
10/03/2002US20020142962 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs
10/03/2002US20020142447 DNA encoding the human serine protease EOS
10/03/2002US20020142446 DNA encoding the human serine protease EOS
10/03/2002US20020142430 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis
10/03/2002US20020142392 Human melanocyte stimulating hormone receptor polypeptide and DNA
10/03/2002US20020142353 Connective tissue growth factor (CTGF) and methods of use
10/03/2002US20020142045 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
10/03/2002US20020142012 Use of flavonoids as immunomodulating or immuno-protective agents in cosmetic and dermatological preparations
10/03/2002US20020141989 Antiinflammatory agents; antiallergens
10/03/2002US20020141987 Fish serine proteinases and their pharmaceutical and cosmetic use
10/03/2002US20020141977 Immunotherapy based on dendritic cells
10/03/2002US20020141956 Skin whiteners containing hydroxytetronic acid derivatives
10/03/2002US20020141953 Topical; carrier and one of 3,3'-thiodipropionic acid, thiazolidine-2-carboxylic acid, and kaempferol-7-glucoside, or their derivatives
10/03/2002CA2442178A1 2-amino-propanol derivatives
10/03/2002CA2441986A1 Methods and products related to fgf dimerization
10/03/2002CA2441893A1 Method of attenuating reactions to skin irritants
10/03/2002CA2441824A1 Use of lipoaminoacids as absorption promoters in a pharmaceutical composition
10/03/2002CA2441806A1 Inosine compounds and their use for treating or preventing an inflammation or a reperfusion disease
10/03/2002CA2441700A1 Polypeptides and nucleic acids for bolekine
10/03/2002CA2441599A1 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain
10/03/2002CA2441588A1 Use of cytokines of the tgf-.beta. superfamily for the treatment and diagnosis of skin related disorders
10/03/2002CA2440676A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
10/03/2002CA2439961A1 Human cytokine receptor
10/03/2002CA2439678A1 Uses of opg ligand to modulate immune responses
10/03/2002CA2436351A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002CA2436340A1 Histidine-rich glycoprotein
10/02/2002EP1245676A1 Human monoclonal antibodies against tgf-beta ii receptor and medicinal use thereof
10/02/2002EP1245237A1 Treatment of skin conditions
10/02/2002EP1245229A2 Methods and compositions for inhibition of angiogenesis
10/02/2002EP1244798A2 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors
10/02/2002EP1244793A2 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same
10/02/2002EP1244790A2 Nucleic acids encoding polypeptides having chips activity
10/02/2002EP1244786A1 Screening method for compounds capable of modularing egr-1-regulated expression
10/02/2002EP1244781A2 Antisense oligonucleotides
10/02/2002EP1244780A2 Dna encoding the human serine protease t
10/02/2002EP1244708A1 Method for treating inflammation
10/02/2002EP1244700A2 Vesicle trafficking proteins
10/02/2002EP1244686A1 Transforming growth factor alpha hiii
10/02/2002EP1244683A1 21 human secreted proteins
10/02/2002EP1244670A1 Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same
10/02/2002EP1244657A2 Sulfonamides and derivatives thereof that modulate the activity of endothelin
10/02/2002EP1244654A1 Tetrahydrothiopy ranphthalazinone derivatives as pde4 inhibitors
10/02/2002EP1244653A1 Non peptide tachykinin receptor antagonists
10/02/2002EP1244649A1 Cyclic amp-specific phosphodiesterase inhibitors
10/02/2002EP1244647A1 Quinazoline derivatives as vegf inhibitors
10/02/2002EP1244643A1 Tryptase inhibitors
10/02/2002EP1244628A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
10/02/2002EP1244626A2 Caspase inhibitors and uses thereof
10/02/2002EP1244620A1 Cyclic amp-specific phosphodiesterase inhibitors
10/02/2002EP1244619A1 Pyrrolidines which inhibit camp-specific pde
10/02/2002EP1244614A2 Tryptase inhibitors
10/02/2002EP1244464A1 Genus leontopodium plant extract and compositions containing same
10/02/2002EP1244463A1 Agent which is anti-adhesive in relation to the pathogenic flora of the skin
10/02/2002EP1244461A2 INHIBITION OF GSK-3$g(b)
10/02/2002EP1244434A2 Use of chemotherapeutic agents
10/02/2002EP1244424A2 Personal care articles comprising a hydrophilic conditioning agent exhibiting a defined leaching value
10/02/2002EP1244418A2 Oil-in-water type cosmetic or dermatological preparations
10/02/2002EP1244401A1 Drug delivery of phase changing formulation
10/02/2002EP1098648B1 Pharmaceutical compositions comprising hydroxylansoprazole and uses thereof
10/02/2002EP1007062A4 Therapeutic use of hemoglobin to treat head injury
10/02/2002EP0928187A4 Antibacterial composition
10/02/2002EP0841946B1 Methods for treatment of allergic asthma
10/02/2002DE10114304A1 Kosmetische und dermatologische Zubereitungen mit einem Gehalt an Hopfen bzw. Hopfen-Malz-Extrakt und Verwendung eines Hopfen- bzw. Hopfen-Malz-Extraktes zur Herstellung kosmetischer und dermatologischer Zubereitungen zur Reduktion des Sebumgehaltes der Haut Cosmetic and dermatological preparations containing hops or hop-malt extract and hops or hop using a malt extract for the preparation of cosmetic and dermatological preparations for reducing the Sebumgehaltes skin
10/02/2002DE10114138A1 Cdk-inhibitorische Indirubinderivate mit erhöhter Löslichkeit Cdk-inhibitory indirubin derivatives with increased solubility
10/02/2002DE10112924A1 1-Butansäurederivate, pharmazeutische Zusammensetzungen enthaltend solche Derivate und Verwendungen solcher Derivate 1-butanoic acid derivatives, pharmaceutical compositions containing such derivatives and uses of such derivatives
10/02/2002CN1372594A OX2 receptor homologs
10/02/2002CN1372569A Keratinocyte growth factor-2
10/02/2002CN1372562A Imidazoimidazoles and triazoles as anti-inflammatory agents
1 ... 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 ... 1065